156 related articles for article (PubMed ID: 30692319)
21. [A New Treatment Strategy-Novel Cell-Free and Concentrated Ascites Reinfusion System(KM-CART)for Massive Malignant Ascites].
Matsusaki K
Gan To Kagaku Ryoho; 2016 Dec; 43(13):2490-2497. PubMed ID: 28028255
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in gastrointestinal cancer patients with massive ascites treated with systemic chemotherapy.
Nagata Y; Kato K; Miyamoto T; Hirano H; Shoji H; Iwasa S; Honma Y; Takashima A; Hamaguchi T; Matsushita H; Nagashima K; Saruta M; Boku N
Support Care Cancer; 2020 Dec; 28(12):5861-5869. PubMed ID: 32253601
[TBL] [Abstract][Full Text] [Related]
23. Ascitic IL-10 Concentration Predicts Prognosis of Patients Undergoing Cell-Free and Concentrated Ascites Reinfusion Therapy.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Ther Apher Dial; 2020 Feb; 24(1):90-95. PubMed ID: 31157953
[TBL] [Abstract][Full Text] [Related]
24. CART: Cell-free and Concentrated Ascites Reinfusion Therapy against malignancy-related ascites.
Ito T; Hanafusa N
Transfus Apher Sci; 2017 Oct; 56(5):703-707. PubMed ID: 28916401
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites.
Yokomichi N; Imai K; Sakamoto M; Horiki M; Yamauchi T; Miwa S; Inoue S; Uneno Y; Suzuki H; Wada T; Ichikawa Y; Morita T
BMC Cancer; 2022 Feb; 22(1):218. PubMed ID: 35227250
[TBL] [Abstract][Full Text] [Related]
26. Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.
Ito T; Hanafusa N; Iwase S; Noiri E; Nangaku M; Nakagawa K; Miyagawa K
Int J Clin Oncol; 2015 Jun; 20(3):623-8. PubMed ID: 25239690
[TBL] [Abstract][Full Text] [Related]
27. Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites.
Matsusaki K; Orihashi K
Artif Organs; 2020 Oct; 44(10):1090-1097. PubMed ID: 32242939
[TBL] [Abstract][Full Text] [Related]
28. Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives.
; Matsusaki K; Ohta K; Yoshizawa A; Gyoda Y
Int J Clin Oncol; 2011 Aug; 16(4):395-400. PubMed ID: 21347629
[TBL] [Abstract][Full Text] [Related]
29. Development of a novel automatic ascites filtration and concentration equipment with multi-ring-type roller pump units for cell-free and concentrated ascites reinfusion therapy.
Okahisa T; Sogabe M; Nakagawa T; Tanaka K; Tomonari T; Taniguchi T; Takahashi A; Kinouchi Y; Nishioka J; Igata N; Yanagawa H; Komatsu T; Ohnishi Y; Fukuhara M; Ishikawa M; Shibata H; Shinomiya H; Nakasono M; Kishi F; Komai K; Tatsuki Y; Murashima T; Deguchi Y; Aramaki H; Fukumitsu H; Takayama T
Artif Organs; 2020 Aug; 44(8):856-872. PubMed ID: 32187379
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of cell-free and concentrated ascites reinfusion therapy (CART) in gynecologic cancer patients with a large volume of ascites.
Wang L; Okubo T; Shinsaka M; Kobayashi A; Ogasawara M; Sakaguchi R; Nagai T; Seki H
J Obstet Gynaecol Res; 2015 Oct; 41(10):1614-20. PubMed ID: 26177394
[TBL] [Abstract][Full Text] [Related]
31. [A Case of Concentrated Ascites Reinfusion Therapy(CART)for Abundant Refractory Ascites in Cecal Cancer with Peritoneal Dissemination Followed by the Readministration of Chemotherapy].
Maemura K; Urakawa S; Kato J; Kidogami S; Fukata T; Nishida H; Ohigashi H; Takemoto H; Fukuzaki T
Gan To Kagaku Ryoho; 2024 Jan; 51(1):93-95. PubMed ID: 38247103
[TBL] [Abstract][Full Text] [Related]
32. Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy.
Namisaki T; Tsuji Y; Kitade M; Yorioka N; Fujinaga Y; Sawada Y; Nishimura N; Kitagawa K; Inoue T; Takaya H; Kaji K; Kawaratani H; Moriya K; Akahane T; Mitoro A; Yoshiji H
In Vivo; 2022; 36(3):1477-1484. PubMed ID: 35478114
[TBL] [Abstract][Full Text] [Related]
33. Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites.
Rossaro L; Graziotto A; Bonato S; Plebani M; van Thiel DH; Burlina A; Naccarato R; Salvagnini M
Dig Dis Sci; 1993 May; 38(5):903-8. PubMed ID: 8482189
[TBL] [Abstract][Full Text] [Related]
34. [Cell-Free and Concentrated Ascites Reinfusion Therapy for Malignant Intractable Ascites from Colorectal Cancer].
Ohta K; Ikenaga M; Ueda M; Iwaki R; Kinoshita T; Mishima K; Shindo K; Chinen Y; Itakura H; Takayama T; Tsuda Y; Nakashima S; Adachi S; Endo S; Yamada T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1556-1558. PubMed ID: 29394700
[TBL] [Abstract][Full Text] [Related]
35. [A Case of Effective Palliative Care with CART for Refractory Ascites Associated with Cancerous Peritonitis of Gastric Cancer].
Kawada J; Nishino M; Hata T; Ogino T; Hoshino H; Okano M; Nagai K; Kim Y; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2018 Apr; 45(4):700-702. PubMed ID: 29650840
[TBL] [Abstract][Full Text] [Related]
36. A Method for Stabilizing the Proportion of the Reduced Form of Albumin During Cell-Free and Concentrated Ascites Reinfusion Therapy in Patients with Malignant Ascites.
Ohashi A; Nakai S; Yamada S; Kato M; Hasegawa M
Ther Apher Dial; 2019 Jun; 23(3):242-247. PubMed ID: 31033167
[TBL] [Abstract][Full Text] [Related]
37. Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.
Yamamoto K; Nagao S; Tsu T; Matsushima T; Ishido Y; Narita M; Suzuki K; Nakazawa H; Shibutani T; Jimi T; Yano H; Kitai M; Shiozaki T; Matsuoka K; Yamaguchi S
J Obstet Gynaecol Res; 2021 Apr; 47(4):1536-1543. PubMed ID: 33469981
[TBL] [Abstract][Full Text] [Related]
38. Prospective study comparing human albumin vs. reinfusion of ultrafiltrate-ascitic fluid after total paracentesis in cirrhotic patients with tense ascites.
Zaak D; Paquet KJ; Kuhn R
Z Gastroenterol; 2001 Jan; 39(1):5-10. PubMed ID: 11215366
[TBL] [Abstract][Full Text] [Related]
39. Clinical usefulness of concentrated ascites reinfusion therapy (CART) for gynecological cancer patients with refractory massive ascites due to cancerous peritonitis.
Togami S; Hori S; Kamio M; Matsuo T; Yoshinaga M; Douchi T
Eur J Gynaecol Oncol; 2014; 35(3):301-3. PubMed ID: 24984546
[TBL] [Abstract][Full Text] [Related]
40. Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
Shimizu S; Ohira M; Nakano R; Imaoka Y; Sato K; Tahara H; Ide K; Kobayashi T; Kuroda S; Ono H; Tanaka Y; Ohdan H
Transplant Proc; 2019 Oct; 51(8):2740-2744. PubMed ID: 31563243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
